Lipohypertrophy and Insulin: An Update From the Diabetes Technology Society

Publikation: Bidrag til tidsskriftKommentar/debatForskningfagfællebedømt

  • Tiffany Tian
  • Rachel E. Aaron
  • Jingtong Huang
  • Andrea M. Yeung
  • Svensson, Jannet
  • Sandro Gentile
  • Angus Forbes
  • Lutz Heinemann
  • Jane Jeffrie Seley
  • David Kerr
  • David C. Klonoff

Lipohypertrophy is a common skin complication associated with insulin-treated diabetes. The impact of lipohypertrophy as a contributing factor to suboptimal glycemic control, glucose variability, and hypoglycemia is often under-recognized by health care professionals. In a recent Webinar on April 26, 2023, Diabetes Technology Society asked international experts to provide updates on the latest knowledge related to lipohypertrophy for practicing clinicians and educators, researchers, and industries involved in insulin delivery. A recording of the Webinar is freely available on the Diabetes Technology Society Web site (

TidsskriftJournal of Diabetes Science and Technology
Udgave nummer6
Sider (fra-til)1711-1721
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The webinar was supported by a grant from Embecta.

Publisher Copyright:
© 2023 Diabetes Technology Society.

ID: 371567513